# The Misuse of Drugs Act 1971 (Amendment) Order 2009, Note: Explanatory note


(This note is not part of the Order)
This Order adds synthetic cannabinoid receptor agonists to Part 2 of Schedule 2 to the Misuse of Drugs Act 1971 (“the Act”) which specifies drugs which are subject to control as Class B drugs under the Act. In addition, the Order adds Gamma-butyrolactone (GBL), 1,4–butanediol (1,4–BD), 15 anabolic steroids, two non-steroidal agents, Oripavine, 1–benzylpiperazine (BZP) and a group of substituted piperazines to Part 3 of Schedule 2 to the Act which specifies drugs which are subject to control as Class C drugs under the Act.

---
Source: https://www.legislation.gov.uk/ukdsi/2009/9780111486610/note (the official version)
Page: https://openlegislation.uk/draft-misuse-of-drugs-act-1971-amendment-order-2009/note
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

